The Patent Finder

Betulin-Containing Birch Bark Extracts and Their Formulation

Amryt Pharmaceuticals Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 16/959,098, filed Jun 29, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,083,733Betulin-Containing Birch Bark Extracts and Their Formulation
In force
 · Medium confidence
UsedRemaining
Amryt Pharmaceuticals Designated Activity CompanyIn forceMedium confidence
US 11,266,660Betulin-Containing Birch Bark Extracts and Their Formulation
In force
 · Medium confidence
Amryt Pharmaceuticals Designated Activity CompanyIn forceMedium confidence
US 11,826,374Betulin-Containing Birch Bark Extracts and Their Formulation
In force
 · Medium confidence
Amryt Pharmaceuticals Designated Activity CompanyIn forceMedium confidence
US 12,268,695Betulin-Containing Birch Bark Extracts and Their Formulation
In force
 · Medium confidence
Amryt Pharmaceuticals Designated Activity CompanyIn forceMedium confidence
Application 16/959,098Betulin-Containing Birch Bark Extracts and Their Formulation
Abandoned
Abandoned Aug 9, 2023
Amryt Pharmaceuticals Designated Activity CompanyAbandonedAbandoned Aug 9, 2023
Application 19/068,545Betulin-Containing Birch Bark Extracts and Their Formulation
Amyrt Pharmaceuticals Designated Activity Company
Pending
Not granted
Amyrt Pharmaceuticals Designated Activity CompanyPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Amryt Pharmaceuticals Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited